Champions Oncology, Inc. (CSBR)
4.94
+0.06
(+1.23%)
USD |
NASDAQ |
Oct 02, 16:00
5.17
+0.23
(+4.66%)
After-Hours: 20:00
Champions Oncology Max Drawdown (5Y) : 78.53% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 78.53% |
| August 31, 2026 | 78.53% |
| July 31, 2026 | 78.53% |
| June 30, 2026 | 78.53% |
| May 31, 2026 | 78.53% |
| April 30, 2026 | 78.53% |
| March 31, 2026 | 78.53% |
| February 28, 2026 | 78.53% |
| January 31, 2026 | 78.53% |
| December 31, 2025 | 78.53% |
| November 30, 2025 | 78.53% |
| October 31, 2025 | 78.53% |
| September 30, 2025 | 78.53% |
| August 31, 2025 | 78.53% |
| July 31, 2025 | 78.53% |
| June 30, 2025 | 78.53% |
| May 31, 2025 | 78.53% |
| April 30, 2025 | 78.53% |
| March 31, 2025 | 78.53% |
| February 28, 2025 | 78.53% |
| January 31, 2025 | 78.53% |
| December 31, 2024 | 78.53% |
| November 30, 2024 | 78.53% |
| October 31, 2024 | 78.53% |
| September 30, 2024 | 78.53% |
| Date | Value |
|---|---|
| August 31, 2024 | 78.53% |
| July 31, 2024 | 78.53% |
| June 30, 2024 | 78.53% |
| May 31, 2024 | 78.53% |
| April 30, 2024 | 78.53% |
| March 31, 2024 | 78.53% |
| February 29, 2024 | 78.53% |
| January 31, 2024 | 78.53% |
| December 31, 2023 | 78.53% |
| November 30, 2023 | 78.53% |
| October 31, 2023 | 78.53% |
| September 30, 2023 | 78.53% |
| August 31, 2023 | 78.53% |
| July 31, 2023 | 78.53% |
| June 30, 2023 | 78.53% |
| May 31, 2023 | 78.53% |
| April 30, 2023 | 82.59% |
| March 31, 2023 | 84.21% |
| February 28, 2023 | 84.74% |
| January 31, 2023 | 85.13% |
| December 31, 2022 | 85.13% |
| November 30, 2022 | 85.13% |
| October 31, 2022 | 85.92% |
| September 30, 2022 | 86.10% |
| August 31, 2022 | 86.62% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Medpace Holdings, Inc. | 42.87% |
| Avantor, Inc. | 83.16% |
| Personalis, Inc. | 98.18% |
| Adaptive Biotechnologies Corp. | 96.55% |
| 10X Genomics, Inc. | 96.47% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -21.47 |
| Beta (5Y) | 0.4380 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 57.98% |
| Historical Sharpe Ratio (5Y) | -0.2948 |
| Historical Sortino (5Y) | -0.6542 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.71% |